Xilio Therapeutics

SVP, Immunology

Xilio Therapeutics • $375K — $425K *
Pharmaceuticals & Biotech
11 - 15 years of experience

About Xilio Therapeutics

Xilio Therapeutics is a clinical-stage biotechnology company that is focused on developing targeted immunotherapies for patients with cancer. The company's proprietary technology platform is designed to enhance the immune system's ability to recognize and attack cancer cells. Xilio's lead product candidate, XTX101, is a tumor-selective IL-2 agonist that is being developed for the treatment of solid tumors. The company is headquartered in Cambridge, Massachusetts.
Learn more about Xilio Therapeutics
Size
50 employees
Market Cap
$58.9 million
Industry
NASDAQ

Similar Jobs

More Jobs at Xilio Therapeutics

More Pharmaceuticals & Biotech Jobs

* Ladders Estimates